Avon Technologies Reports Strong Q1 Demand and Reaffirms Full-Year Guidance

Avon Technologies Q1 Trading Update: Record Start, Guidance Reaffirmed

Avon Technologies has kicked off FY26 with a confident trading update ahead of today’s AGM in Melksham. The headline is simple: strong demand, especially in Avon Protection, and no change to full-year guidance. There’s a wobble at Team Wendy due to the U.S. government shutdown, but management frames it as temporary and recoverable from Q2.

For a business rooted in protective equipment for military and law enforcement, the demand backdrop remains robust. The company talks up a “record start” to the year and a healthy order book and sales pipeline – two signals that revenue visibility is solid.

Key takeaways for investors from Avon’s Q1 update

• Avon Protection delivered a record start to the year, driven by sustained CBRN demand and good operational gearing.
• Team Wendy had a slower Q1 due to U.S. government shutdown delays to product testing and deliveries, which pushed down Department of War and federal revenue.
• Margins at Team Wendy were held back by planned investment ahead of a production ramp in Q2.
• Full-year guidance is unchanged; management expects higher revenue and better operational gearing over the rest of FY26, assuming no further shutdowns.
• Strategy is shifting toward growth in 2026, with investment in key programmes and new products to expand addressable markets.

What’s working: Avon Protection’s record start

Avon Protection continues to benefit from strong demand for CBRN kit – that’s chemical, biological, radiological and nuclear protection gear. The update points to “good operational gearing”, which means fixed costs are covered and incremental revenue drops through to profit more effectively. Pair that with a “healthy order book and sales pipeline” and you’ve got a mix that tends to underpin earnings momentum.

Management also reiterates the continuous improvement theme. The operational step-up isn’t an isolated win – it’s coming from ongoing process upgrades, which should be good news for margins as volumes scale.

What’s lagging: Team Wendy’s Q1 slowdown explained

Team Wendy remains well booked but had a softer quarter. The U.S. government shutdown delayed testing and deliveries, denting Department of War and broader federal revenue in Q1. That sort of delay doesn’t usually imply lost demand – it’s a timing issue – but it does shift revenue and cash collection to later in the year.

Management says the margin hit was compounded by a planned increase in investment ahead of higher production in Q2. In plain English: they spent ahead of the ramp. The company expects higher revenue, inventory unwind and improved operational gearing over the rest of FY26, provided there are no further extended shutdowns.

Why the shutdown matters for Team Wendy

Helmet systems and related protective equipment often require formal testing and acceptance before shipment. A shutdown stalls these processes, creating a backlog. If government operations normalise, those backlogs typically clear, which aligns with Avon’s expectation of a Q2 pick-up.

Guidance: steady as she goes

Avon is sticking with the full-year guidance communicated at the FY25 results in November. Specific numbers are not disclosed in today’s RNS. The CEO adds that the Group remains “on track to meet or exceed” FY26 financial targets, but again, those targets are not detailed here.

Investor read-across: holding guidance after a record start sounds prudent. Some might have hoped for an early upgrade, but given the Team Wendy timing issues and ongoing operational work in Cleveland, keeping powder dry is sensible.

Strategy update: from fix-and-stabilise to growth mode

The CEO highlights a clear pivot. After three years of stabilising and strengthening the Group, 2026 is about growth: investing in key programmes and new products to reinforce competitive positioning and expand addressable markets. Early signs are described as “promising”.

There’s also a frank nod to ongoing efficiency work at the Cleveland facility. Progress is being made, but productivity still has room to improve – a realistic acknowledgement and a key execution watch-out for the year.

Jargon buster: quick definitions

• CBRN: Chemical, Biological, Radiological and Nuclear – specialised protective gear for high-risk environments.
• Operational gearing: the degree to which profits rise faster than sales once fixed costs are covered.
• Order book: contracted orders yet to be delivered; a proxy for future revenue.
• Sales pipeline: qualified potential orders; visibility into medium-term demand.
• Inventory unwind: reducing stock levels as deliveries accelerate, often releasing cash and improving working capital.

What’s not disclosed in the RNS

• Q1 revenue, order intake and margin figures – not disclosed.
• Size of the order book and pipeline – not disclosed.
• Cash, net debt and working capital position – not disclosed.
• Numerical FY26 guidance targets – not disclosed in this update.

Risks and watch points for the months ahead

• Further U.S. government shutdowns: explicitly flagged as a risk that would push out testing and deliveries again.
• Cleveland facility execution: management says momentum is improving, but productivity remains a focus area.
• Timing of inventory unwind: key to margins and cash conversion in H1 and H2.
• Delivery schedules vs testing cycles: any slippage here would defer revenue recognition.

Dates and catalysts investors should note

My take: a solid update with a realistic caveat

This reads as a business with strong end-market demand and improving execution, particularly in Avon Protection. The temporary drag at Team Wendy is understandable given the shutdown, and the company has been clear about the assumptions for a Q2 ramp. Unchanged guidance feels appropriately conservative given moving parts and the Cleveland to-do list.

The more interesting medium-term angle is the shift to growth: investing in programmes and new products to expand the addressable market. That should, if executed well, support sustained top-line growth and leverage the operational gearing Avon is already seeing. Interim Results on 13 May will be the litmus test for the Q2 catch-up and the pace of margin improvement.

Bottom line: demand is there, execution is key

• Positive: record start at Avon Protection, healthy order book and pipeline, and a credible plan to scale.
• Negative: Team Wendy’s Q1 dip and ongoing efficiency work in Cleveland keep some uncertainty in the near term.
• Net result: guidance held, tone confident, and clear catalysts ahead – a sensible update that keeps the FY26 story intact.

You can find the AGM presentation and more about the business at www.avon-technologiesplc.com. I’ll be watching for confirmation of the Q2 production ramp and how quickly inventories unwind to support margins and cash flow.